SEC insider transactions · retrieved 2026-09-30 · 2026 Q2: filings in this completed quarter; not a live transaction feed
Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.
Transaction rows by code · counts, not monetary totals
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
0 matching transaction rows.
No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.
Identity & relationships
Wikidata structured data · retrieved 2026-09-30 · 1613 unambiguous CIK-linked entities; coverage is incomplete
These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.
SEC issuer · 0001091326BIOMOLECULAR LIFE HOLDINGS, INC.
No parent relationship is available in this import; this is not proof of independence.
SB Technology Holdings, Inc. · former SEC name · 2026-05-04 to 2026-05-04
VG Life Sciences Inc. · former SEC name · 2014-11-13 to 2026-03-06
VG Life Sciences, Inc. · former SEC name · 2014-06-20 to 2014-10-14
VIRAL GENETICS INC /DE/ · former SEC name · 2002-04-01 to 2009-03-25
5 STARLIVING ONLINE INC · former SEC name · 1999-07-29 to 2001-10-18
Revenue in constant purchasing power
USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.
No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.